Related by context. All words. (Click for frequent words.) 70 Amplimexon 69 Archexin 68 GFT# 68 Azedra 67 PRT# 67 liposomal formulation 66 oral prodrug 66 Solulin 66 ZOLINZA 66 metaglidasen 66 CIMZIA TM 66 TRO# 66 Arikace 66 ReN# 66 YONDELIS 66 torezolid phosphate 66 TriRima 66 IRX 2 66 INCB# [001] 66 Viprinex 65 CCX# 65 RhuDex ® 65 ATL# [001] 65 BrachySil TM 65 lomitapide 65 VAPRISOL 65 oral rivaroxaban 65 inhaled iloprost 65 KNS # 65 vorinostat 65 Mipomersen 65 Tasimelteon 65 anti amnesic 65 AEG# 65 anticancer compound 65 reslizumab 65 thetreatment 65 Dabigatran etexilate 65 PEGylated interferon 65 Insegia 65 paclitaxel poliglumex 65 OHR/AVR# 65 ISTODAX 65 Symadex 65 Onconase 65 Nanobody 65 Dapagliflozin 64 Omacetaxine 64 Tamibarotene 64 Xanafide 64 Interferon alpha 64 indibulin 64 small molecule tyrosine 64 desmoteplase 64 TREDAPTIVE 64 sulodexide 64 targeted radiotherapeutic 64 Desmoteplase 64 synthetic retinoid 64 diabetic neuropathic pain 64 VA# [002] 64 imexon 64 MNTX 64 Rasagiline 64 ATL# [002] 64 Vernakalant 64 GW# [003] 64 R#/MEM # 64 GRN# 64 renin inhibitor 64 Lodotra 64 immune modulatory 64 acadesine 64 Bicifadine 64 Alvesco R 64 PHX# 64 preclinically 64 novel VDA molecule 64 Ganciclovir 64 interferon beta therapy 64 vascular disrupting agent 64 riociguat 64 therapeutic monoclonal antibody 64 CBLC# 64 CCR9 antagonist 64 Panzem R 64 selective orally bioavailable 64 somatostatin analog 64 Vaprisol 64 Pimavanserin 64 HuLuc# 64 Cloretazine 64 elvucitabine 63 AZILECT ® 63 ADAGIO study 63 REMINYL ® 63 anticancer agent 63 Traficet EN 63 Bezielle 63 vidofludimus 63 DU #b 63 ALN TTR 63 pain palliation 63 ALGRX 63 IMA# 63 Vidofludimus 63 mertansine 63 obatoclax 63 HCV protease inhibitors 63 cannabinor 63 antithrombotic agents 63 Alferon N 63 ThGRF 63 LHRH antagonist 63 Glypromate 63 Laquinimod 63 RLY# 63 dexpramipexole 63 Proellex TM 63 Zoraxel 63 ancrod 63 PD LID 63 Hsp# Inhibitor 63 YONDELIS R 63 Tyrima 63 sitaxsentan 63 SNT MC# 63 tezampanel 63 Safinamide 63 favorable pharmacokinetic profile 63 CIMZIA ™ 63 PSN# [001] 63 AZILECT R 63 ATL/TV# 63 HQK 63 intranasal formulation 63 ospemifene 63 Sym# 63 HuMax EGFr 63 Clevudine 63 edoxaban 63 histone deacetylase inhibitor 63 octreotide acetate 63 fosbretabulin 63 oral FTY# 63 IPLEX 63 alteplase 63 PEGylated anti 63 XmAb# 63 pioglitazone HCl 63 antiplatelet agent 63 TLK# 63 deferiprone 63 alvespimycin 63 ulimorelin 63 Cetrorelix 63 Dacogen decitabine 63 HGS# 63 eniluracil 63 CGEN # 62 Revascor TM 62 TPI ASM8 62 cathepsin K inhibitor 62 elotuzumab 62 IMiDs ® 62 DP VPA 62 lurasidone 62 Vascugel 62 Tofacitinib 62 docetaxel Taxotere ® 62 Durezol 62 Pertuzumab 62 TH# [003] 62 orally bioavailable 62 BNC# 62 trodusquemine 62 selective modulator 62 Aviptadil 62 PEG SN# 62 TNF alpha inhibitor 62 SERMs 62 MAGE A3 ASCI 62 UPLYSO 62 azilsartan medoxomil 62 DDP# 62 Allovectin 7 ® 62 tipranavir 62 Silodosin 62 JAK2 inhibitor 62 #D#C# 62 elacytarabine 62 CRMD# 62 NTx TM -# 62 teriflunomide 62 Virulizin ® 62 nucleotide analog 62 Anavex #-# 62 varespladib 62 otelixizumab 62 Azilect ® 62 Tarceva TM 62 Maribavir 62 antiangiogenic agent 62 tanespimycin 62 oral salmon calcitonin 62 angiotensin receptor blocker ARB 62 pharmacokinetic profile 62 receptor tyrosine kinase inhibitor 62 PI3K/Akt pathway inhibitor 62 Sapacitabine 62 oral antiviral 62 Squalamine 62 ORMD 62 MoxDuo IR 62 gefitinib Iressa 62 RoACTEMRA 62 vosaroxin 62 Spiegelmer ® 62 phase IIb clinical 62 xanthine oxidase inhibitor 62 Pemetrexed 62 NeuVax 62 GSK# [001] 62 intensive lipid lowering 62 Dasatinib 62 histone deacetylase HDAC inhibitor 62 MEK inhibitor 62 Ophena TM 62 NP2 Enkephalin 62 Nanobody ® 62 dosage regimens 62 systemically administered 62 deforolimus 62 antitumor effect 62 JAK inhibitor 62 TBC# 62 GAMMAGARD 62 Olmesartan 62 thymalfasin 62 immunotherapeutic vaccine 62 Relivar 62 mGluR2 NAM 62 PDE4 inhibitor 62 schizophrenia CIAS 62 Tesmilifene 62 MGd 62 MKC# MKC# PP 62 OMNARIS HFA 62 Serdaxin 62 huN# DM1 62 COPAXONE R 62 CTAP# Capsules 62 MoxDuo 62 nanopharmaceutical 62 pertuzumab 62 prostone 62 luliconazole 62 eprotirome 62 PRTX 62 RhuDex 62 Pitavastatin 62 Imprime PGG 62 Preclinical studies suggest 62 Golimumab 62 antithrombotic 61 Lu AA# 61 recombinant tissue plasminogen 61 polymerase inhibitor 61 perampanel 61 TG# [003] 61 active moiety 61 Catena ® 61 Zerenex 61 Davanat 61 CA4P 61 bicifadine 61 HDACi 61 Phase #/#a 61 Anthim 61 novel oral anticoagulant 61 AAG geldanamycin analog 61 either acutely decompensated 61 Muraglitazar 61 Elvitegravir 61 orBec 61 LY# [003] 61 platelet inhibitor 61 subcutaneous SC 61 NeuroSTAT ® 61 methylnaltrexone 61 placebo controlled clinical 61 highly selective inhibitor 61 selective inhibition 61 Solasia 61 2 methoxyestradiol 61 PSMA ADC 61 SERCA2a 61 OvaRex R 61 dasatinib Sprycel 61 rhIGF-I/rhIGFBP-3 61 Naproxcinod 61 mTOR inhibition 61 levodopa induced dyskinesia 61 oral renin inhibitor 61 hyperphenylalaninemia HPA due 61 Elacytarabine 61 relapsed MM 61 direct thrombin inhibitors 61 Phase #b/#a trial 61 EOquin TM 61 Vidaza azacitidine 61 trabectedin 61 orally administered inhibitor 61 OXi# 61 Elesclomol 61 TAFA# 61 CYT# potent vascular disrupting 61 GLYX 61 OncoVEX 61 thrombolytic agent 61 Liposomal 61 Serdolect ® 61 leukotriene receptor antagonist 61 Æterna Zentaris 61 mGluR5 NAM 61 Perforomist ™ Inhalation Solution 61 Afatinib 61 PrevOnco ™ 61 OMP #M# 61 XYOTAX TM 61 Fulvestrant 61 forodesine 61 Nanobodies 61 OncoGel 61 EndoTAG TM -1 61 generation purine nucleoside 61 bardoxolone 61 APTIVUS 61 Toraymyxin TM 61 Certican 61 Panzem R NCD 61 GGF2 61 casopitant 61 JVRS 61 PrevOnco 61 efficacy tolerability 61 Exherin TM 61 muraglitazar 61 NMDA antagonist 61 OncoVEX GM CSF 61 PF # [001] 61 Aclidinium 61 peripherally acting 61 DermaVir Patch 61 Nexavar ® 61 LibiGel ® 61 Huntexil 61 Pirfenidone 61 oral anticoagulant 61 CEQ# 61 IMiDs 61 ozarelix 61 radiation sensitizer 61 candidate deforolimus 61 Dalbavancin 61 enzastaurin 61 DACH platinum 61 ANAVEX #-# [003] 61 kidney urologic 61 paricalcitol 61 cilengitide 61 desvenlafaxine succinate 61 ADP receptor antagonist 61 Zysolin TM 61 HuMax CD4 61 Clonicel 61 EndoTAGTM 1 61 pitavastatin 61 Teriflunomide 61 MEVACOR 61 thalidomide Thalomid 61 rufinamide 61 proteasome inhibitor 61 Proxinium TM 61 pharmacodynamic properties 61 RSD# 61 Darusentan 61 leading oral taxane 61 teduglutide 61 LymphoStat B belimumab 61 pharmacodynamic profile 61 phase IIa clinical 61 Fodosine 61 Tarvacin 61 uricase 61 safinamide 61 KAPVAY ™ 61 beta 1a 61 hormone LHRH antagonist 61 drug ISA# 61 acyclovir Lauriad R 61 mGluR5 antagonist 61 solithromycin 61 plasma kallikrein 61 ALN TTR# 61 Gleevec resistant 61 long acting muscarinic 61 estramustine 61 BrachySil 61 Factor Xa inhibitor 61 ANAVEX #-# [001] 61 TYZEKA 61 ACZ# 61 HIF PH inhibitors 61 KRN# 61 echinocandin 61 GMX# 61 modified REGENESIS Phase IIb 61 afamelanotide 61 IAP inhibitor 61 Teysuno 61 EP #R 61 dissolving clots 61 chimeric monoclonal antibody 61 CCR5 antagonist 61 intravenous AAT 61 HuMax CD# 61 somatostatin analogue 61 PLX cells 61 Lixivaptan 61 cardiac repolarization 61 HyACT 61 NTx ® -# 61 RELOVAIR ™ 61 Talabostat 60 ZFP TF 60 TMC# [002] 60 effector function 60 viral kinetics 60 Plenaxis TM 60 PKC# 60 rilonacept 60 Ophena 60 ThermoDox R 60 orally dosed 60 histamine dihydrochloride 60 allogeneic cell 60 ProSavin 60 Q#IR 60 Onrigin 60 boosted protease inhibitor 60 Valdoxan 60 ELND# 60 evaluating tivozanib 60 BAY #-# 60 5 HT3 antagonist 60 Irinotecan 60 phase IIb trial 60 anti arrhythmic 60 BMS # 60 CCR5 inhibitor 60 sorafenib tablets 60 ganetespib 60 bortezomib Velcade 60 inhibitor RG# 60 r hGH 60 MYDICAR ® 60 Plicera 60 maximally tolerated dose 60 amphotericin B 60 nucleoside analog 60 ARIKACE ™ 60 VDAs 60 selective serotonin 2C receptor 60 trabedersen 60 novel prodrug 60 Soliris eculizumab 60 stated Michelle Berrey 60 IFN beta 60 EVIZON TM 60 intravenously administered 60 amrubicin 60 BENICAR 60 injectable formulation 60 Chemophase 60 Anturol TM 60 OvaRex MAb 60 malignant ascites 60 cMET 60 Alpharadin 60 NOX E# 60 beta2 agonist 60 Phase #b/#a 60 AEGR 60 rxRNA 60 SCH # 60 Phase 1b trial 60 BEXXAR 60 Phenoptin 60 JAK inhibitors 60 Factor VIIa 60 ixabepilone 60 maximally tolerated 60 anti TNF alpha 60 PSN# [002] 60 Nimotuzumab 60 mAb 60 MAP# 60 nalbuphine ER 60 oral deforolimus 60 Revimmune 60 GVAX Pancreas Vaccine 60 Certolizumab pegol 60 Aflibercept 60 Androxal TM 60 pharmacodynamic PD 60 glatiramer 60 pharmacokinetic PK study 60 ENMD # 60 Cloretazine R VNP#M 60 Alfimeprase 60 CytoFabTM 60 NNR Therapeutics 60 noninfectious uveitis 60 Allovectin 7 60 Zolinza 60 maximal dose 60 plasma kallikrein inhibitor 60 LT NS# 60 nicotinic alpha 7 60 Dacogen injection 60 Dual Opioid 60 refractory prostate cancer 60 atacicept 60 AKT inhibitor 60 RE LY ® 60 Raptiva ® 60 Zoledronic acid 60 Lubiprostone 60 Elagolix 60 RAPAFLO 60 TNF Tumor Necrosis Factor 60 CRLX# 60 clobazam 60 glatiramer acetate 60 radiotherapeutic 60 R#/MEM 60 HGS ETR1 mapatumumab 60 ThermoDox ® 60 Acute Ischemic Stroke 60 LHRH antagonists 60 Fx #A 60 Melphalan 60 dosing cohort 60 bendamustine HCl 60 subcutaneous formulation 60 CDP# 60 tecarfarin 60 active comparator 60 D Pharm 60 Genz # 60 Advagraf 60 JANUVIA 60 Sitagliptin 60 PI3K inhibitor 60 Hemopurifier ® 60 oral taxane 60 velafermin 60 DXL# 60 mild vasodilator 60 Trofex 60 APTIVUS r 60 SGLT2 inhibitors 60 azacitidine 60 Ampakine 60 TEMODAL 60 FFNS 60 SPRIX ® 60 Zemplar Capsules 60 EZN 60 Icatibant 60 iobenguane 60 Tezampanel 60 PTP 1B 60 ICA # 60 selective adenosine 60 Ecallantide 60 thrombotic diseases 60 Forodesine HCl 60 canakinumab 60 bendamustine 60 Pazopanib 60 Aplidin 60 IMiDs R 60 CXB# 60 Octreolin 60 BZL# 60 investigational HCV polymerase 60 tesmilifene 60 anticancer activity 60 DuraSite 60 pan HDAC inhibitor 60 Degarelix 60 HIF 1a 60 MabCampath 60 Ramelteon 60 Tarvacin TM 60 celgosivir 60 Pancreate 60 Oral NKTR 60 LEUKINE 60 Menerba 60 samalizumab 60 Darinaparsin 60 #ME# 60 Enhanze Technology 60 olmesartan 60 p# inhibitor 60 Anticalins R 60 Vimpat R 60 rasagiline tablets 60 Carfilzomib 60 orally inhaled migraine 60 USL# 60 Cloretazine ® 60 SIR Spheres 60 Viprinex TM 60 PhG alpha 1 60 Hsp# inhibitor 60 Phase Ib study 60 insulin sensitizer 60 ISIS # 60 BENICAR HCT 60 sodium glucose cotransporter 60 OvaRex ® MAb 60 Aptivus ® 60 PRLX # 60 Lisofylline 60 Beta catenin pathway 60 TRV# [001] 60 CINQUIL 60 ELACYT 60 fluoropyrimidine 60 investigational therapies 60 uric acid lowering 60 PDE# inhibitors 60 PEGylated Fab fragment 60 LEP ETU 60 MGN# 60 volociximab 60 silodosin 60 BAL# [002] 60 angiogenesis inhibitor 60 topically administered 60 anticancer therapies 60 Fentanyl TAIFUN R 60 rALLy clinical trial 60 AzaSite Plus 60 mitogen activated ERK kinase 60 Phase IIb clinical trials 60 zileuton 60 NV1FGF 60 Exelixis compounds 60 PORxin TM 60 PROCHYMAL 60 VitiGam 60 erythropoietic 60 MKC# 60 VEGF receptor 60 Firazyr 60 preclinical efficacy 60 SRT# [003] 60 icatibant 60 Prodarsan ® 59 Evoltra ® 59 PLX STROKE targeting 59 Kissei Pharmaceutical 59 Peginterferon alfa 2b 59 radezolid 59 alefacept 59 custirsen 59 virus HCV protease inhibitor 59 sorafenib Nexavar 59 Bucindolol 59 Debio 59 Orazol 59 clevidipine 59 Phase IIa trials 59 QTinno TM 59 EndoTAG 59 pegfilgrastim 59 Pathway Inhibitor 59 Sanvar R 59 miRview mets 59 tesetaxel 59 pharmacokinetic interactions 59 AGILECT R 59 selective androgen receptor modulator 59 Combination therapy 59 DCCR 59 Asentar 59 corticosteroid dexamethasone 59 StemEx R 59 GLPG# 59 tezampanel NGX# 59 Nanobodies ® 59 IgG1 antibody 59 hPTH #-# 59 Triapine 59 Genasense ® oblimersen 59 Orally administered 59 non nucleoside 59 tumor vascular disrupting 59 IGF 1R inhibitor 59 gemcitabine Gemzar ® 59 anti EGFR antibody 59 BRIM2 59 oral methylnaltrexone 59 SUTENT ® 59 dexanabinol 59 Potelligent Technology 59 BGC# 59 Personalized Immunotherapy 59 palonosetron 59 targeted antifolate 59 GSK# [002] 59 Panzem 59 MET inhibitor 59 leukotriene pathway 59 pegylated liposomal doxorubicin 59 lumiliximab 59 pyridostigmine 59 isoform selective 59 Onalta 59 INT# [002] 59 dosing frequency 59 Trobalt 59 alagebrium 59 Amrubicin 59 metastatic malignant 59 Enkephalin 59 omega interferon 59 citicoline 59 sargramostim 59 HCV protease inhibitor 59 romidepsin 59 sd rxRNA 59 Tekamlo 59 MEK inhibitors 59 THR beta agonist 59 mTOR inhibitor 59 IPX# 59 PN# [001] 59 pharmacokinetic PK profile 59 Urocidin TM 59 pharmacodynamic effects 59 ONCASPAR 59 NGX# 59 gemcitabine cisplatin 59 Evoltra 59 registrational 59 ciclesonide 59 cystinosis patients 59 CYT# 59 demonstrated antitumor activity 59 Phase IIb trials 59 blood clot dissolver 59 RSD# oral 59 Diamyd ® 59 Pyridorin 59 Cancidas 59 KSP inhibitor 59 CCR5 mAb 59 GLP1 agonist 59 MT#/MEDI-# 59 immunomodulator 59 baminercept 59 VNP#M 59 tumor necrosis 59 KAPIDEX 59 LAB CGRP 59 peptibody 59 systemic antifungal 59 Kahalalide F 59 Sudhir Agrawal D.Phil 59 bardoxolone methyl 59 DexaSite 59 Virulizin R 59 Fabry Disease 59 integrase inhibitor 59 eculizumab 59 catheter occlusion 59 NasalFent 59 Oxytrex 59 Intravenous CP 59 Natalizumab 59 CG# [003] 59 tolerated dose MTD 59 non nucleoside inhibitor 59 rhITF 59 siRNA therapeutic 59 Alocrest 59 farletuzumab 59 LB# [003] 59 ribavirin RBV 59 cardioprotection 59 Velcade bortezomib 59 Marqibo TM 59 Flutiform TM 59 C1 INH 59 PNP inhibitor 59 davunetide intranasal AL 59 aleglitazar 59 adalimumab Humira 59 EFAPROXYN 59 injectable formulations 59 Tesetaxel 59 Spiriva Handihaler 59 neuroprotectant 59 mTOR inhibitors 59 SEPET TM 59 Urocortin 2 59 erlotinib Tarceva 59 AVONEX ® 59 docetaxel Taxotere R 59 XP #L 59 ATPace TM 59 Civacir 59 fluticasone furoate 59 Cerovive 59 IIa trials 59 Tanespimycin 59 tramiprosate 59 REG1 59 immunomodulatory therapy 59 SYGNIS 59 regorafenib 59 intranasal delivery 59 Amigal 59 Aurexis 59 FRDA 59 pomalidomide 59 Myocet 59 ALB # 59 ibandronate 59 Behcet uveitis 59 UVIDEM 59 herpetic keratitis 59 tenofovir emtricitabine 59 Elocalcitol 59 systemic immunosuppressive drugs 59 acute ischemic stroke 59 protease inhibitor PI 59 Daclizumab 59 Bendamustine 59 rHuPH# 59 delta opioid receptor 59 induced macular edema 59 RAPTIVA 59 thromboxane A2 59 INTEGRILIN R 59 TG# [001] 59 partial agonist 59 Maraviroc 59 Crofelemer 59 EVIZON 59 pharmacologic agents 59 LEVADEX ™ 59 Toctino ® alitretinoin 59 antitumor effects 59 BioNumerik 59 IMiDs ® compound 59 neuroprotective properties 59 hour bronchodilation 59 Phase #b/#a clinical 59 vivo validation 59 Yondelis ® 59 ganaxolone 59 rt PA 59 alkylating agent 59 tocilizumab 59 biologic therapy 59 humanized monoclonal 59 oxypurinol 59 Zerenex ™ 59 Poly ICLC 59 peptidomimetic 59 HuCAL antibodies 59 rFVIIIFc 59 PRX# 59 SonoLysis 59 vascular disrupting 59 modulator SERM 59 AeroLEF TM 59 paclitaxel Taxol 59 novel histone deacetylase 59 Apoptone 59 antisense oligonucleotide 59 Zingo TM 59 Methylnaltrexone 59 AZOR 59 Rotigotine 59 Inhalation Solution 59 NVA# 59 pharmacokinetic characteristics 59 Val HeFT 59 Phase III Clinical Trial 59 nitazoxanide 59 XP# XP# 59 Annamycin 59 HepeX B 59 inhaled AAT 59 Edoxaban 59 MTP inhibitor 59 LCP AtorFen 59 Pafuramidine 59 ceftazidime 59 Lovaza TM 59 ® natalizumab 59 Glufosfamide 59 KB# [002] 59 DepoDur 59 CA9 SCAN 59 CorVue ™ 59 assessing T DM1 59 Cand5 59 TELINTRA 59 pharmacological chaperone 59 prospective randomized placebo 59 tolvaptan 59 Liprostin 59 Temsirolimus 59 pegylated alpha interferon 59 vascular disrupting agents 59 XL# anticancer compounds 59 ularitide 59 MYDICAR 59 anti angiogenic agent 59 recurrent glioma 59 bioequivalency 59 Tocilizumab 59 ACTEMRA TM 59 maturation inhibitor 59 vinca alkaloid 59 taxane derivative 59 Aptocine 59 bortezomib Velcade ® 59 Lenalidomide 59 Cethrin R 59 HCD# [002] 59 Eltrombopag 59 CR# vcMMAE 59 Phase 2a trial 59 Nippon Shinyaku 59 ToGA 59 Ixempra 59 multicenter Phase II 59 Ciclesonide 59 Zoraxel TM 59 TKB# 59 MVA BN 59 RECOTHROM R 59 BiTE 59 Ceflatonin R 59 Troxatyl 59 IMP# 59 relapsed ALL 59 epigenetic therapies 59 ponatinib 59 AIR# [001] 59 Zybrestat 59 cinacalcet 59 SPC# [001] 59 BCR ABL inhibitors 59 aclidinium 59 urocortin 2 59 delipidation 59 Allovectin 7 R 59 Lisofylline LSF 59 Cimzia TM 59 Multiple Ascending Dose 59 Zalypsis 59 opioid induced bowel dysfunction 59 PREOS R 59 rNAPc2 59 complete cytogenetic response 59 TRISENOX 59 rALLy trial 59 depsipeptide 59 APOPTONE 59 aliskiren amlodipine 58 NXL# 58 clinical pharmacology studies 58 recurrent glioblastoma multiforme 58 Bortezomib 58 protein kinase inhibitor 58 beta Estradiol 58 eritoran 58 Curaxin CBLC#